Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.

Item
http://www.wikidata.org/entity/Q37097049
Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyTrefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: crosstalk between Bcl2 and caspase 3.Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer.Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.Bcl2 and Ki67 refine prognostication in luminal breast cancers.
P2860

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.

Item
http://www.wikidata.org/entity/Q37097049
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@en
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@nl
type
label
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@en
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@nl
prefLabel
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@en
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Prognostic value of Bcl-2 in t ...... th adjuvant endocrine therapy.
@en
P2093
P2860
P304
P31
P356
10.3109/0284186X.2011.653009
P433
P478
P50
P577
P698
P921
P932